Immucell Corp (ICCC) Reports Q1 EPS of $0.11
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Price: $10.06 -0.3%
Financial Fact:
Product development expenses: 307.72K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Product development expenses: 307.72K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q1 EPS of $0.11, versus $0.15 reported last year. Revenue for the quarter came in at $2.99 million, versus $3.1 million reported last year.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
- Arena Group to rename as Paradium.AI, ticker changing to PAAI
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
